About
Dr. Romal Stewart is a neuroscientist who currently serves as a Research Officer at the Cellular and Molecular Neurodegeneration Laboratory within QIMR Berghofer. As an early career researcher, his primary focus lies in harnessing the potential of iPSC-derived brain organoids, often referred to as "mini-Brains", to unveil the intricate cellular and molecular intricacies underlying neurodegenerative disorders and neuroinflammation. His expertise extends to studying conditions such Alzheimer's Disease (AD), motor neuron disease (MND), and Multiple sclerosis (MS) and neurological long-COVID.
Dr. Stewart's academic contributions are noteworthy, with a total of 13 co-authored publications to his credit. Among his recent achievements is a first-author publication that delves into the heightened neurovirulence of omicron BA.5 when tested in human brain organoids. His research endeavours have been well-supported, securing over $800,000 in competitive grant funding, with more than $100,000 as lead investigator (CIA).